Tumor Microenvironment ROS/pH Cascade-Responsive Supramolecular Nanoplatform with ROS Regeneration Property for Enhanced Hepatocellular Carcinoma Therapy

• Published in: ACS applied materials & interfaces 2024-02, Vol.16 (6), p.7576-7592
• Main Authors: Shi, Jinfeng, Wang, Yehui, Wu, Yihan, Li, Jingjing, Fu, Chaomei, Li, Yi, Xie, Xingliang, Fan, Xiaohong, Hu, Yichen, Hu, Chuan, Zhang, Jinming
• Format: Article
• Language: English
• Subjects: Carcinoma, Hepatocellular - drug therapy; Cell Line, Tumor; Functional Nanostructured Materials (including low-D carbon); Humans; Hydrogen-Ion Concentration; Liver Neoplasms - drug therapy; Nanoparticles - chemistry; Reactive Oxygen Species; Regeneration; Tumor Microenvironment
• ISSN: 1944-8244; 1944-8252
• DOI: 10.1021/acsami.3c16022

The low targeted drug delivery efficiency, including poor tumor accumulation and penetration and uncontrolled drug release, leads to the failure of cancer therapy. Herein, a multifunctional supramolecular nanoplatform loading triptolide (TPL/PBAETK@GA NPs) was fabricated via the host–guest interaction between glycyrrhetinic-acid-modified poly­(ethylene glycol)-adamantanecarboxylic acid moiety and reactive oxygen species (ROS)/pH cascade-responsive copolymer poly­(β-amino esters)-thioketal (TK)-β-cyclodextrin. TPL/PBAETK@GA NPs could accumulate in hepatocellular carcinoma (HCC) tissue effectively, mediated by nanoscale advantage and GA’ recognition to specific receptors. The elevated concentration of ROS in tumor microenvironment (TME) quickly breaks the TK linkages, causing the detachment of shell (cyclodextrin) CD layer. Then, the accompanying negative-to-positive charge-reversal of NPs was realized via the PBAE moiety protonation under the slightly acidic TME, significantly enhancing the NPs’ cellular internalization. Remarkably, the pH-responsive endo/lysosome escape of PBAE core triggered intracellular TPL burst release, promoting the cancer cell apoptosis, autophagy, and intracellular ROS generation, leading to the self-amplification of ROS in TME. Afterward, the ROS positive-feedback loop was generated to further promote size-shrinkage and charge-reversal of NPs. Both in vitro and in vivo tests verified that TPL/PBAETK@GA NPs produced a satisfactory anti-HCC therapy outcome. Collectively, this study offers a potential appealing paradigm to enhance TPL-based HCC therapy outcomes via multifunctionalized supramolecular nanodrugs.